Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million

Having completed its IPO roadshow, closed books, and established the official IPO price, Symetis, the leading European structural heart player, received a definitive, all-cash offer from Boston Scientific to purchase the Company

Published last April Thursday 27, 2017

Healthcare newsletter

Welcome to Bryan, Garnier & Co’s March 2017 Healthcare newsletter

Published last April Tuesday 4, 2017

Automotive Technologies

Welcome to the first in a new series of “Market Watch" reports about the Automotive sector

Published last March Monday 20, 2017

Receive Alerts

Enter your email to receive our news and offers.